Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,2612,280 of 20,252 grants

Active OTHER RESEARCH-RELATED
Use and Impact of Quantitative Information in Tobacco Risk Communications
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2023 – 2027

Project Summary/Abstract In 2019, nearly 14 of every 100 U.S. adults aged 18-years or older (14.0%) currently smoked cigarettes. Current strategies of tobacco use risk communicatio...

$1.14M
USD
Active NON-SBIR/STTR RPGS
Inflammation And Submucosal Glands During Esophageal Injury And Repair
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The etiology of Barrett's esophagus (BE), a complex metaplastic disorder of the distal esophagus, remains elusive. Patients with BE are at an increased risk of...

Active NON-SBIR/STTR RPGS
EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The etiology of Barrett's esophagus (BE), a molecularly complex disorder of the distal esophagus, remains elusive. Patients with BE are at an increase...

Active NON-SBIR/STTR RPGS
Bioreagents & Resources Core
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The Biospecimen and Reagents Core [BRC] provides high quality annotated specimens and expert pathology consultation to enhance the P01 projects. The BR&C CWRU a...

Active OTHER RESEARCH-RELATED
University of New Mexico's CURE for Cancer
NATIONAL CANCER INSTITUTE University of New Mexico Health Scis Ctr United States 2023 – 2028

ABSTRACT / SUMMARY Responding to community concerns related to higher cancer incidences and worse outcomes among New Mexico’s ethnically and racially diverse communities, the Unive...

$4.1M
USD
Active NON-SBIR/STTR RPGS
Integrative Systems Biology Core
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The Integrative Systems Biology Core will interact with all investigators to develop and apply appropriate analysis methods and designs to most efficiently...

Active NON-SBIR/STTR RPGS
Project 2: Ex Vivo Modeling and Analysis of Gastric Precancerous Lesions
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – PROJECT 2 The central purpose of Project 2 is to utilize a primary human tissue model to investigate the features of gastric stem cells and how the cells interact with H...

Active NON-SBIR/STTR RPGS
Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – PROJECT 3 Project 3 proposes a concerted effort to decrease the 10-15% rate of Helicobacter pylori (Hp) recrudescence that is currently experienced by patients. Previous...

Active NON-SBIR/STTR RPGS
Core A: Administrative
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – ADMINISTRATIVE CORE A The overarching goal of the Administrative Core is to provide the operational support necessary to meet the goals of each Project and the overall P...

Active NON-SBIR/STTR RPGS
Core B: Translational, Cellular and Molecular Analysis
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – CELLULAR IMAGING AND GENOMICS CORE B Core B, the Cellular Genomics and Imaging Core (CGI), will provide centralized experimental processing services and primary data ana...

Active NON-SBIR/STTR RPGS
Core C: Biostatistics
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – BIOSTATISTICS CORE C The goal of the Biostatistics Core is to provide support for the statistical analysis generated from three projects. These supportive functions incl...

Active NON-SBIR/STTR RPGS
Leveraging whole-exome sequence data from diverse biobanks and cohorts to study rare coding variation in prostate cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2028

Abstract There is strong evidence that prostate cancer (PCa) is a heritable phenotype. In addition to greater risk observed in men with a family history of PCa, genome-wide associa...

$6.35M
USD
Active NON-SBIR/STTR RPGS
Probing the role of somatic X-chromosome alterations in shaping cancer sex differences
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY Cancer is a major global public health problem and the second leading cause of death in the United States. Many cancer types display differences in incidence betwee...

$5.19M
USD
Completed NON-SBIR/STTR RPGS
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

ABSTRACT The SETER/PR index of sensitivity to endocrine therapy measures endocrine receptor-related transcription from formalin-fixed paraffin-embedded tumor sections and is highly...

$3.52M
USD
Active OTHER RESEARCH-RELATED
Privacy-Aware Federated Learning for Breast Cancer Risk Assessment
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

ABSTRACT: Federated learning (FL) has gained a lot of attention recently, as it enables analyses of data from numerous collaborating sites without the need to share data, i.e., eac...

$6.97M
USD
Active NON-SBIR/STTR RPGS
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Breast cancer patients represent fast-growing medical cannabis and cannabinoid (MCC) users in this country; a recent survey indicates that about 42% of bre...

$6.18M
USD
Active NON-SBIR/STTR RPGS
Metabolic effects of cooper in renal cancer
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2023 – 2028

Clear cell renal cell carcinoma (ccRCC) is a frequent and malignant renal cancer with a glycolytic phenotype due to the loss of VHL tumor suppressor and activation of HIF transcrip...

$5.13M
USD
Completed OTHER RESEARCH-RELATED
Role of BCL11B in lineage ambiguous leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2025

PROJECT SUMMARY Acute leukemias of ambiguous lineage (ALAL) are high-risk leukemia subtypes and include mixed phenotype acute leukemia (MPAL) and early T cell precursor acute lymph...

$1.36M
USD
Completed SBIR-STTR RPGS
Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings
NATIONAL CANCER INSTITUTE Lifegene-Biomarks, Inc United States 2023 – 2024

Project Summary A diagnosis of Head and neck squamous cell carcinoma (HNSCC) includes many cancer subtypes. We will focus on the oral cavity squamous cell carcinoma (OSCC) subtype...

$2.92M
USD
Active NON-SBIR/STTR RPGS
Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell Carcinomas
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2023 – 2026

Principal Investigator: FM Fernández – Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell Carcinomas Understanding complex chemical and biological alterations in cancer...

$2.15M
USD